• +971 0000 000 000
  • info@verticaljournal.top

Cytek Biosciences Chief Technology Officer Trades Company's Stock

Grand News Network | October 24, 2023

Ming Yan, Chief Technology Officer at Cytek Biosciences (NASDAQ:CTKB), reported a large insider sell on October 24, according to a new SEC filing.

What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Yan sold 20,000 shares of Cytek Biosciences. The total transaction amounted to $96,000.

Cytek Biosciences shares are trading down 1.08% at $4.57 at the time of this writing on Tuesday morning.

Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.

The Importance of Insider Transactions

Insider transactions shouldn't be used primarily to make an investing decision, ...

Full story available on Benzinga.com


Disclaimer: The views, recommendations, and opinions expressed in this content belong solely to the third-party experts. This site was not involved in the writing and production of this article.


Disclaimer Press Release Banner